Vivien Fagan

IQVIA

Vivien has 25 years of experience in an international CRO and, over the past 22 years, has written numerous regulatory documents (including protocols and CSRs) for all phases of studies for a variety of pharmaceutical sponsors and biotechnology companies. In her current position as Director, Global Medical Writing, Vivien manages IQVIA’s Medical Writing group based in Livingston, Scotland. She is the also Global Head of IQVIA’s Clinical Trial Disclosure group. From May 2014, Vivien was a member of the Budapest Working Group CORE Reference de novo Review Team. On the topic of CORE Reference, Vivien is an EMWA Workshop Leader and DIA panellist.